Pakistan
· Delayed Price · Currency is PKR IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 2.70 billion. The enterprise value is 2.82 billion.
| Market Cap | 2.70B |
| Enterprise Value | 2.82B |
Important Dates
The next estimated earnings date is Wednesday, October 2, 2024.
| Earnings Date | Oct 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 85.67 million shares outstanding. The number of shares has increased by 0.34% in one year.
| Shares Outstanding | 85.67M |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | +0.79% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 2.80% |
| Float | 23.30M |
Valuation Ratios
The trailing PE ratio is 12.17.
| PE Ratio | 12.17 |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | 1.18 |
| P/FCF Ratio | 19.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.89, with an EV/FCF ratio of 20.44.
| EV / Earnings | 12.71 |
| EV / Sales | 0.67 |
| EV / EBITDA | 5.89 |
| EV / EBIT | 5.97 |
| EV / FCF | 20.44 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 9.86.
| Current Ratio | 2.34 |
| Quick Ratio | 1.63 |
| Debt / Equity | 9.86 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | 1.64 |
| Interest Coverage | 6.98 |
Financial Efficiency
Return on equity (ROE) is 10.20% and return on invested capital (ROIC) is 12.14%.
| Return on Equity (ROE) | 10.20% |
| Return on Assets (ROA) | 8.07% |
| Return on Capital (ROIC) | 12.14% |
| Revenue Per Employee | 13.50M |
| Profits Per Employee | 714,183 |
| Employee Count | 311 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 2.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +12.21% |
| 50-Day Moving Average | 31.12 |
| 200-Day Moving Average | 33.07 |
| Relative Strength Index (RSI) | 53.91 |
| Average Volume (20 Days) | 77,248 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 4.20 billion and earned 222.11 million in profits. Earnings per share was 2.59.
| Revenue | 4.20B |
| Gross Profit | 1.45B |
| Operating Income | 472.57M |
| Pretax Income | 335.82M |
| Net Income | 222.11M |
| EBITDA | 476.14M |
| EBIT | 472.57M |
| Earnings Per Share (EPS) | 2.59 |
Balance Sheet
The company has 101.92 million in cash and 225.74 million in debt, giving a net cash position of -123.83 million or -1.45 per share.
| Cash & Cash Equivalents | 101.92M |
| Total Debt | 225.74M |
| Net Cash | -123.83M |
| Net Cash Per Share | -1.45 |
| Equity (Book Value) | 2.29B |
| Book Value Per Share | 26.72 |
| Working Capital | 1.68B |
Cash Flow
In the last 12 months, operating cash flow was 140.73 million and capital expenditures -2.66 million, giving a free cash flow of 138.07 million.
| Operating Cash Flow | 140.73M |
| Capital Expenditures | -2.66M |
| Free Cash Flow | 138.07M |
| FCF Per Share | 1.61 |
Margins
Gross margin is 34.51%, with operating and profit margins of 11.25% and 5.29%.
| Gross Margin | 34.51% |
| Operating Margin | 11.25% |
| Pretax Margin | 8.00% |
| Profit Margin | 5.29% |
| EBITDA Margin | 11.34% |
| EBIT Margin | 11.25% |
| FCF Margin | 3.29% |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.81% |
| Buyback Yield | -0.34% |
| Shareholder Yield | -0.34% |
| Earnings Yield | 8.21% |
| FCF Yield | 5.12% |
Stock Splits
The last stock split was on October 19, 2023. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 19, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2 |